Wedge Capital Management L L P Harvard Bioscience Inc Transaction History

Wedge Capital Management L L P

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$5.44 - $8.4 $430,320 - $664,465	-79,103 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$3.91 - $6.99 $247,022 - $441,607	-63,177 Reduced 44.4%	79,103 $432,000
Q2 2020 Jul 10, 2020	SELL	$2.12 - $3.14 $20,165 - $29,867	-9,512 Reduced 6.27%	142,280 $441,000
Q1 2020 Apr 13, 2020	BUY	$1.42 - $3.29 $70,961 - $164,411	49,973 Added 49.08%	151,792 $335,000
Q4 2019 Jan 15, 2020	SELL	$2.45 - $3.25 $604,003 - $801,229	-246,532 Reduced 70.77%	101,819 $311,000
Q3 2019 Nov 01, 2019	BUY	$1.59 - $3.47 $553,878 - $1.21 Million	348,351 New	348,351 $1.07 Million
Q2 2019 Aug 01, 2019	SELL	$1.93 - $4.59 $455,663 - $1.08 Million	-236,095 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$2.77 - $4.38 $255,261 - $403,625	92,152 Added 64.02%	236,095 $1.02 Million
Q3 2018 Nov 01, 2018	SELL	$5.0 - $6.65 $125,055 - $166,323	-25,011 Reduced 14.8%	143,943 $756,000
Q2 2018 Jul 31, 2018	BUY	$4.2 - $5.95 $386,589 - $547,667	92,045 Added 119.68%	168,954 $904,000
Q1 2018 May 01, 2018	BUY	$3.3 - $5.15 $253,799 - $396,081	76,909 New	76,909 $385,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.